Skip to main content
. 2014 Jan 9;105(1):97–104. doi: 10.1111/cas.12319

Figure 2.

Figure 2

Event-free survival (EFS) of patients with acute promylocytic leukemia (APL) according to CD56 expression. (a) EFS for all patients showed an inferior trend in CD56+ APL (47.8% vs 64.8% at 9 years, P = 0.08). (b) In patients whose white blood cell (WBC) count was ≥3.0 × 109/L, EFS for CD56+ APL was significantly inferior to that for CD56 APL (30.8% vs 63.8%, P = 0.008).